| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 07/11/2006 | US7074416 Antigen of hybrid M protein and carrier for group A streptococcal vaccine |
| 07/11/2006 | US7074415 Polypeptide antigens of streptococcus pneumoniae pathogen which may be useful for prophylaxis, diagnostic or treatment of streptococcal infection |
| 07/11/2006 | US7074414 Cold-adapted equine influenza viruses |
| 07/11/2006 | US7074413 Using reverse genetics to combine the antigenic determinants that render the rabies virus non-pathogenic with the determinants that are responsible for the elicitation of an effective anti-rabies immune response |
| 07/11/2006 | US7074411 α-β C4BP-type recombinant heteromultimeric proteins |
| 07/11/2006 | US7074410 Modified HCV peptide vaccines |
| 07/11/2006 | US7074409 Polypeptides having a triggering NK activity and biological applications |
| 07/11/2006 | US7074408 Use of integrin antagonists to inhibit angiogenesis |
| 07/11/2006 | US7074407 immunizing with fragments of CETP (cholesteryl ester transfer protein) which may be conjugated to a carrier, such as KLH (keyhole limpet hemocyanin) or ovalbumin, to increase immunogenicity |
| 07/11/2006 | US7074403 Immunotherapy of autoimmune disorders using antibodies which target B-cells |
| 07/11/2006 | US7074402 Treating different types of neuronal dysfunction, including stroke, Alzheimer's disease, Parkinson's disease, Huntington disease, neuroimmunological disorders such as multiple scelrosis |
| 07/11/2006 | US7074400 Regulatory constructs comprising intron 3 of prostate specific membrane antigen gene |
| 07/11/2006 | US7074397 Method for enhancing proliferation or differentiation of a cell using ob protein |
| 07/11/2006 | CA2440583C A proteinase inhibitor, precursor thereof and genetic sequences encoding same |
| 07/11/2006 | CA2277983C Tyrosine phosphorylated cleavage furrow-associated proteins (pstpips) |
| 07/11/2006 | CA2176463C Hu-b1.219, a novel human hematopoietin receptor |
| 07/11/2006 | CA2078549C Multiple sclerosis t-cell receptor |
| 07/06/2006 | WO2006072065A2 Pcv2 immunogenic compositions and methods of producing such compositions |
| 07/06/2006 | WO2006071949A2 Zebrafish heterotrimer g-protein gamma 2 subunit (gng2) |
| 07/06/2006 | WO2006071840A2 Formulations of human growth hormone comprising a non-naturally encoded amino acid |
| 07/06/2006 | WO2006071822A1 Exotoxin inhibitory factor |
| 07/06/2006 | WO2006071746A2 Engineered dopamine neurons and uses thereof |
| 07/06/2006 | WO2006071219A1 Improved grain quality through altered expression of seed proteins |
| 07/06/2006 | WO2006071082A1 Human protooncogene and protein encoded by same, and expression vector containing same |
| 07/06/2006 | WO2006071081A1 Human cancer suppressor gene, protein encoded therein, expression vector containing same |
| 07/06/2006 | WO2006071080A1 Human protooncogene and protein encoded therein |
| 07/06/2006 | WO2006070371A2 Method for obtaining modified proteins and viruses with intact native binding site |
| 07/06/2006 | WO2006070028A1 Pathogenic infection detection compositions and methods |
| 07/06/2006 | WO2006070011A1 Methods to obtain recombinant proteins with increased sialylation from cells that express adenovirus e1a protein, and proteins obtained thereby |
| 07/06/2006 | WO2006069940A1 Method for preventing formation of trisulfide derivatives of polypeptides |
| 07/06/2006 | WO2006069779A1 Preparing of peptides with excellent solubility |
| 07/06/2006 | WO2006069765A2 Secreted polypeptide species involved in multiple sclerosis |
| 07/06/2006 | WO2006069729A1 Synthesis of peptide t-1249 using peptide intermediate fragments |
| 07/06/2006 | WO2006069728A1 Synthesis of peptide t-20 using peptide intermediate fragments |
| 07/06/2006 | WO2006069727A2 Synthesis of peptide t-20 using peptide intermediate fragments |
| 07/06/2006 | WO2006069718A1 Immunogenic compositions of cyclic peptides derived from the beta-amyloid peptide |
| 07/06/2006 | WO2006069711A1 Multiple promoters and the use thereof for gene expression |
| 07/06/2006 | WO2006069588A2 Biocine s2ha a biocontrol substance for controlling brown rot disease on otato |
| 07/06/2006 | WO2006069449A1 Chemokine receptor-independent immunomodulatory and anti-proliferative activity |
| 07/06/2006 | WO2006047687A3 Compositions and methods for short interfering nucleic acid inhibition of nav1.8 |
| 07/06/2006 | WO2006046963A9 Generation of virus-like particles and use as panfilovirus vaccine |
| 07/06/2006 | WO2006046073A3 C1q related protein |
| 07/06/2006 | WO2006044840A8 Soluble zcytor21, anti-zcytor21 antibodies and binding partners and methods of using in inflammation |
| 07/06/2006 | WO2006044566A9 Autocrine growth factor receptors and methods |
| 07/06/2006 | WO2006044480A3 Nematode resistant transgenic plants |
| 07/06/2006 | WO2006043060A3 Mam domain containing protein |
| 07/06/2006 | WO2006031689A3 Multimeric constructs |
| 07/06/2006 | WO2006029838A3 Secreted polypeptide species involved in alzheimer’s disease |
| 07/06/2006 | WO2006020040A3 Apolipoprotein a1 mimetics and uses thereof |
| 07/06/2006 | WO2006017833A3 Genetic loci associated with phytophthora tolerance in soybean |
| 07/06/2006 | WO2006016525A3 Genes and polypeptides relating to breast cancers |
| 07/06/2006 | WO2006014540A3 Plant n-acylethanolamine binding proteins |
| 07/06/2006 | WO2006007202A3 Canine cd20 compositions |
| 07/06/2006 | WO2006000830A3 Cells expressing a modified t cell receptor |
| 07/06/2006 | WO2005118626A3 Peptides for inducing a ctl and/or htl response to hepatitis c virus |
| 07/06/2006 | WO2005116072A3 Antibodies as t cell receptor mimics, methods of production and uses thereof |
| 07/06/2006 | WO2005082077A3 Novel bacillus thuringiensis crystal polypeptides, polynucleotides, and compositions thereof |
| 07/06/2006 | WO2005049639A3 Compositions and methods for protein isolation |
| 07/06/2006 | WO2005010022A3 Agonist polypeptide of receptor for zot and zonulin |
| 07/06/2006 | WO2005003326A3 Artificial receptors including reversibly immobilized building blocks and methods |
| 07/06/2006 | WO2005003313A8 Methods and compositions for enhanced protein expression and purification |
| 07/06/2006 | WO2004112565A3 Diagnosis and treatment of liver, pulmonary and cardiac fibrosis |
| 07/06/2006 | WO2004084805A3 Acetylated tat polypeptides and methods of use thereof |
| 07/06/2006 | WO2004072096A3 Peptides binding gp120 of hiv-1 |
| 07/06/2006 | WO2004043232A3 Methods for identifying risk of melanoma and treatments thereof |
| 07/06/2006 | WO2004034031A3 A method for diagnosis and prognosis of multiple sclerosis |
| 07/06/2006 | WO2003080797A3 6 human secreted proteins |
| 07/06/2006 | WO2003066829A3 Factors for angiogenesis, vasculogenesis, cartilage formation, bone formation and methods of use thereof |
| 07/06/2006 | US20060150284 Gene expression element specific for Ah receptor ligands and heterologous gene expression systems dependent on the element |
| 07/06/2006 | US20060150278 Method for generating maize plants with an increased leaf starch content, and their use for making maize silage |
| 07/06/2006 | US20060150276 Insecticidal proteins; biological pest control; genetic molecules encoding plant floral defensin-like molecules and their use in generating transgenic plants having resistance or at least reduced sensitivity to plant pests |
| 07/06/2006 | US20060150267 Methods of using testis-specific insulin homolog polypeptides |
| 07/06/2006 | US20060150266 TRP6 calcium channel disruptions, compositions and methods related thereto |
| 07/06/2006 | US20060150265 Transgenic mice containing sulfotransferase gene disruptions |
| 07/06/2006 | US20060150262 Novel mucin-like polypeptides |
| 07/06/2006 | US20060149521 Modulating nuclear receptor coactivator binding |
| 07/06/2006 | US20060149050 Isolation and method of using tissue growth-inducing Frzb |
| 07/06/2006 | US20060149049 Stem cell growth factor-like ployeptides |
| 07/06/2006 | US20060149040 Collagen and method for producing same |
| 07/06/2006 | US20060149039 Pseudo-native chemical ligation |
| 07/06/2006 | US20060149038 PRO211 polypeptides |
| 07/06/2006 | US20060149037 Cupredoxin derived transport agents and methods of use thereof |
| 07/06/2006 | US20060149036 Composition and method for self-assembly and mineralizatin of peptide amphiphiles |
| 07/06/2006 | US20060149034 Homing peptides to receptors of heart vasculature |
| 07/06/2006 | US20060149033 IGF antagonist peptides |
| 07/06/2006 | US20060149032 Recombinant hepatitis B surface antigen |
| 07/06/2006 | US20060148750 Polynucleotide vaccines expressing codon optimized HIV-1 Pol and modified HIV-1 Pol |
| 07/06/2006 | US20060148718 complex of cytotoxic agent to polypeptides; amino acid sequence proteolytic splitting protate specific antigen; therapy for protate cancer and benign prostate hyperplasia |
| 07/06/2006 | US20060148717 Biocidal proteins |
| 07/06/2006 | US20060148714 Therapeutic peptide-based constructs |
| 07/06/2006 | US20060148713 Use of exendins and agonists thereof for the reduction of food intake |
| 07/06/2006 | US20060148710 Oligopeptides, composition and use thereof as elicitors of the natural defences of plants |
| 07/06/2006 | US20060148709 Neuroprotective properties of GDF-15, a novel member of the TGF-Beta superfamily |
| 07/06/2006 | US20060148708 C5a receptor |
| 07/06/2006 | US20060148705 Nucleic acids; fusion proteins; binding to endothelial growth factor; fusion polypeptides capable of binding vascular endothelial cell growth factor (VEGF), VEGF family members, and splice variants with specifically desirable characteristics; therapy for ocular diseases |
| 07/06/2006 | US20060148701 Methyl or 2-propyl ester; acute respiratory distress syndrome, pneumonia, bronchitis, meconim aspiration syndrome, cystic fibrosis |
| 07/06/2006 | US20060148696 Contacting macrophage or T-cell with an effective amount of a cyclophilin from Toxoplasma or biologically active fragment thereof to inhibit HIV (human immunodeficiency virus) infection of a cell; kit with instructions |
| 07/06/2006 | US20060148692 Novel protein and its dna |
| 07/06/2006 | US20060148690 Secreted peptides |
| 07/06/2006 | US20060148689 A peptide consisting of a sequence comprising a tripeptide and tetrapeptide linked or existing separately with specific recognition of lipid vectors, particularly negativelycharged phosphatides on cell surfaces; stability; labels;fluorescence; imaging contrast agents; kitsanalyzing; diagnosis/medical |